Results 111 to 120 of about 112,548 (301)

A STUDY ON EFFICACY OF AUTOLOGOUS PLATELET RICH PLASMA IN MYRINGOPLASTY [PDF]

open access: yes, 2013
Objective: To study the efficacy and advantage in using autologus platelet rich plasma during myringoplasty in closure of tympanic membrane perforation   preventing the graft displacement, promoting quicker healing & improving overall outcome.Methods
Gopalakrishnan, Sankaranarayanan   +2 more
core   +1 more source

Successful treatment of an equine orosinus fistula using a titanium screw

open access: yesEquine Veterinary Education, EarlyView.
Summary This case report outlines the long‐term successful treatment of a non‐healing orosinus fistula with placement of a 16‐mm diameter titanium screw within the compromised alveolus. A 7‐year‐old mare presented for investigation of a 2‐month long chronic right‐sided sinusitis, which had been unresponsive to several courses of broad‐spectrum ...
L. Lamont   +2 more
wiley   +1 more source

Possible association of short‐term complications and antimicrobial use in standing equine cheek tooth extractions 2018–2022

open access: yesEquine Veterinary Journal, EarlyView.
Abstract Background Despite growing concerns about antimicrobial resistance, prophylactic antimicrobials continue to be routinely administered in many procedures, including dental extractions. Further evidence‐based research is needed on whether their use influences post‐operative complication rates.
Marlies Schnierer   +4 more
wiley   +1 more source

Identification of the Cytokines, Growth Factors and Their Receptors Expressed by Human Blood Eosinophils: A Transcriptomics Approach

open access: yes
Clinical &Experimental Allergy, EarlyView.
Stephane Esnault   +10 more
wiley   +1 more source

A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To assess the safety, tolerability, and treatment effects of rimegepant 75 mg every other calendar day (EOD) for the preventive treatment of migraine in a 52‐week, open‐label extension (OLE) study. Background Rimegepant is an oral small molecule calcitonin gene–related peptide receptor antagonist approved for the acute treatment of ...
David Kudrow   +3 more
wiley   +1 more source

The TRIP database showed most Acute Respiratory Infections questions were already addressed by Cochrane reviews [PDF]

open access: yes, 2019
Brassey, Jon   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy